teva pharmaceuticals introduces the first generic glp-1 for weight loss Wegovy Pill Wins FDA Approval as Oral Treatment Obesity and GLP-1 Clinical Practice Updates: August
Description
doi: 10.1080/13543784.2023.2283020
At the cost of roughly $12,000 annually, bariatric surgery may remain a better long-term bargain
Clinical trial data and post-marketing surveillance have not confirmed an increased incidence of medullary thyroid carcinoma in GLP-1RA-treated patients, though long-term monitoring continues [30,31]
"Myostatin/activin receptor ligands in muscle and the development status of attenuating drugs." Endocrine Reviews 43.2 (2022): 329-365
